Magnesium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulfate is an inorganic salt that is an essential electrolyte. It plays a crucial role in numerous biochemical reactions, including muscle and nerve function, cardiac rhythm, blood glucose control, and blood pressure regulation. ## Primary Indications * **Hypomagnesemia:** Treatment of magnesium deficiency. * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures in pregnant patients with severe preeclampsia or eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia (torsades de pointes) associated with a prolonged QT interval. * **Asthma:** Adjunctive therapy for severe, life-threatening asthma exacerbations that are refractory to standard treatment. ## Adult Dosing Dosing is highly dependent on indication and patient status. Specific protocols are often utilized, especially for eclampsia and severe asthma. * **Hypomagnesemia:** * **Mild Deficiency:** 1 gram (8 mEq) magnesium sulfate IM or IV every 6 hours for 4 doses. * **Severe Deficiency/Symptomatic:** 4 to 5 grams (32 to 40 mEq) magnesium sulfate added to 1 L of intravenous fluid, infused over 15 to 60 minutes, followed by a maintenance infusion of 1 gram (8 mEq) per hour. Monitor serum magnesium levels closely. * **Eclampsia/Preeclampsia:** * **Loading Dose:** 4 to 6 grams magnesium sulfate IV, administered as a bolus over 5 to 10 minutes, followed by 2 grams per hour infusion. Alternative protocols may exist. * **IM Dosing (alternative):** 5 grams magnesium sulfate IM in each buttock (total 10 grams) followed by 5 grams IM every 4 hours. * **Torsades de Pointes:** 1 to 2 grams (8 to 16 mEq) magnesium sulfate diluted in 10 to 20 mL D5W IV over 5 to 10 minutes. Further doses may be given, or an infusion of 0.5 to 1 gram (4 to 8 mEq) per hour may be initiated. * **Asthma:** 2 grams magnesium sulfate diluted in 50 mL normal saline IV infusion over 15 to 30 minutes. ## Pediatric Dosing Pediatric dosing is less well-established and often follows institutional guidelines. * **Hypomagnesemia:** Dosing varies widely based on age, weight, and severity of deficiency. Typical doses range from 25 to 50 mg/kg per dose IV, not to exceed 2 grams per dose. Continuous infusions may also be used. * **Eclampsia/Preeclampsia:** Dosing is extrapolated from adult regimens and may be weight-based. * **Asthma:** Typically 25 to 50 mg/kg IV infusion over 15 to 30 minutes, not to exceed 2 grams. ## Dose Adjustments * **Renal Impairment:** Magnesium sulfate is renally excreted. In patients with significant renal impairment, doses should be reduced, and serum magnesium levels must be closely monitored to avoid accumulation and toxicity. Avoid use in severe renal failure. ## Contraindications * **Hypermagnesemia:** Contraindicated in patients with elevated serum magnesium levels. * **Heart Block:** Contraindicated in patients with heart block (unless a pacemaker is in place). * **Myocardial Infarction:** Generally avoided in acute myocardial infarction due to potential for myocardial depression. * **Hypersensitivity:** Known hypersensitivity to magnesium sulfate. ## Adverse Effects The most common adverse effects are related to excessive magnesium levels and include: * **Neurological:** Flushing, sweating, hypotension, nausea, vomiting, drowsiness, decreased reflexes, muscle weakness, respiratory depression, cardiac arrhythmias, cardiac arrest, coma. * **Cardiovascular:** Hypotension, bradycardia, ECG changes. * **Gastrointestinal:** Diarrhea (with oral administration). Magnesium toxicity typically occurs when serum magnesium levels exceed 4 mEq/L (approximately 9.6 mg/dL). ## Key Drug Interactions * **Neuromuscular Blocking Agents (e.g., succinylcholine, rocuronium):** Magnesium sulfate can potentiate neuromuscular blockade, increasing the risk of prolonged paralysis and respiratory depression. * **Calcium Channel Blockers:** Additive hypotensive and cardiac effects may occur. * **Antibiotics (e.g., tetracyclines, quinolones):** Magnesium may decrease the absorption of oral tetracyclines and fluoroquinolones. Administer these agents at least 2 hours before or 4 to 6 hours after magnesium sulfate. * **Digoxin:** High doses of magnesium may affect cardiac conduction and increase digoxin toxicity. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with IV infusions and in patients with renal impairment. Target levels vary by indication (e.g., 4-7 mEq/L for eclampsia, 1.7-2.6 mEq/L for hypomagnesemia). * **Renal Function:** Assess baseline and monitor as needed. * **Deep Tendon Reflexes:** Assess for loss of reflexes, which can indicate toxicity. * **Respiratory Rate and Depth:** Monitor for signs of respiratory depression. * **Blood Pressure and Heart Rate:** Monitor for hypotension and bradycardia. * **Urine Output:** Monitor for adequate urine output, which is crucial for magnesium excretion. ## Clinical Pearls * Magnesium sulfate is administered either intramuscularly (IM) or intravenously (IV). IM injections can be painful; consider lidocaine with the injection. * Rapid IV infusion can cause hypotension and cardiac depression. Always dilute and infuse as prescribed. * Calcium gluconate or calcium chloride should be readily available as an antidote for magnesium toxicity. * When treating hypomagnesemia, consider the underlying cause (e.g., gastrointestinal losses, alcoholism, diuretic use). *** **Disclaimer:** This information is intended for clinical pharmacy professionals. It is essential to consult the most current prescribing information and institutional protocols for definitive guidance. Drug information is constantly evolving.